Amit Yelne

Background

About Amit Yelne

I am a highly motivated professional with a background in regulatory toxicology and a passion for business development in the pharmaceutical industry. In July 2019, I completed my MS (M.Pharm) in Regulatory Toxicology at the esteemed National Institute of Pharmaceutical Education and Research (NIPER) in Hyderabad. I had the opportunity to work as a Business Development Executive at Vivo Biotech Ltd in Hyderabad. In this role, I actively generated leads, familiarized myself with ICH/OECD GLP/FDA Redbook guidelines, and participated in various preclinical research activities, including in vitro and in vivo toxicology studies. Additionally, I successfully interacted with clients, understood their requirements, executed proposals, and provided quotations. I was promoted to Assistant Manager in Business Development at Vivo Biotech in May 2021. In this role, I focused on toxicity, genotoxicity, analytical, biocompatibility studies, and regulatory submissions in compliance with OECD/Schedule Y/New Drug and Clinical Trial, 2019/OCSPP/EU/ICH/ISO guidelines. I played a key role in revenue generation, client acquisition, and the development and execution of new business activities. Additionally, I effectively coordinated various projects, managed sales activities, and facilitated client meetings. I possess a comprehensive understanding of GLP certified labs, NABL, CPCSEA, CIBRC, and other industry standards. In March 2023, I joined Intox Aragen Company as a Senior Executive Project Management. In this position, I have the privilege of interacting with foreign clients and overseeing studies related to Non-Human Primates Models (Dogs, Monkeys, etc.). I actively participate in project management activities, including the execution of proposals and the utilization of Salesforce app and Proventis to maintain and organize data on study-related activities. I am dedicated to leveraging my expertise in regulatory toxicology, business development, and project management to drive success and contribute to the growth of the pharmaceutical industry. Feel free to reach out to discuss collaborations, industry insights, or any other opportunities of mutual interest.